261 related articles for article (PubMed ID: 34391740)
1. Prognostic Importance of Health Status Versus Functional Status in Heart Failure and Secondary Mitral Regurgitation.
Arnold SV; Stone GW; Jain SS; Mack MJ; Saxon JT; Zhang Z; Lindenfeld J; Abraham WT; Cohen DJ;
JACC Heart Fail; 2021 Sep; 9(9):684-692. PubMed ID: 34391740
[TBL] [Abstract][Full Text] [Related]
2. Health Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation: COAPT Trial.
Arnold SV; Stone GW; Mack MJ; Chhatriwalla AK; Austin BA; Zhang Z; Ben-Yehuda O; Kar S; Lim DS; Lindenfeld J; Abraham WT; Cohen DJ;
J Am Coll Cardiol; 2020 May; 75(17):2099-2106. PubMed ID: 32194195
[TBL] [Abstract][Full Text] [Related]
3. Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
Arnold SV; Chinnakondepalli KM; Spertus JA; Magnuson EA; Baron SJ; Kar S; Lim DS; Mishell JM; Abraham WT; Lindenfeld JA; Mack MJ; Stone GW; Cohen DJ;
J Am Coll Cardiol; 2019 May; 73(17):2123-2132. PubMed ID: 30894288
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT Trial.
Grayburn PA; Sannino A; Cohen DJ; Kar S; Lim DS; Mishell JM; Whisenant BK; Rinaldi MJ; Kapadia SR; Rajagopal V; Crowley A; Kotinkaduwa LN; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
J Am Coll Cardiol; 2020 Sep; 76(9):1007-1014. PubMed ID: 32854834
[TBL] [Abstract][Full Text] [Related]
5. Baseline Functional Capacity and Transcatheter Mitral Valve Repair in Heart Failure With Secondary Mitral Regurgitation.
Malik UI; Ambrosy AP; Ku IA; Mishell JM; Kar S; Lim DS; Whisenant BK; Cohen DJ; Arnold SV; Kotinkaduwa LN; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
JACC Cardiovasc Interv; 2020 Oct; 13(20):2331-2341. PubMed ID: 33092707
[TBL] [Abstract][Full Text] [Related]
6. Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes: A Secondary Analysis of the COAPT Trial.
Lindenfeld J; Abraham WT; Grayburn PA; Kar S; Asch FM; Lim DS; Nie H; Singhal P; Sundareswaran KS; Weissman NJ; Mack MJ; Stone GW;
JAMA Cardiol; 2021 Apr; 6(4):427-436. PubMed ID: 33533873
[TBL] [Abstract][Full Text] [Related]
7. Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry.
Arnold SV; Li Z; Vemulapalli S; Baron SJ; Mack MJ; Kosinski AS; Reynolds MR; Hermiller JB; Rumsfeld JS; Cohen DJ
JAMA Cardiol; 2018 Dec; 3(12):1151-1159. PubMed ID: 30476950
[TBL] [Abstract][Full Text] [Related]
8. Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial.
Shahim B; Cohen DJ; Ben-Yehuda O; Redfors B; Kar S; Lim DS; Arnold SV; Li Y; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
J Am Heart Assoc; 2023 Feb; 12(4):e028444. PubMed ID: 36752227
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial.
Kosmidou I; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Kipperman RM; Boudoulas KD; Redfors B; Shahim B; Zhang Z; Mack MJ; Stone GW
Circ Heart Fail; 2020 Nov; 13(11):e007293. PubMed ID: 33176460
[TBL] [Abstract][Full Text] [Related]
10. Impact of COPD on Outcomes After MitraClip for Secondary Mitral Regurgitation: The COAPT Trial.
Saxon JT; Cohen DJ; Chhatriwalla AK; Kotinkaduwa LN; Kar S; Lim DS; Abraham WT; Lindenfeld J; Mack MJ; Arnold SV; Stone GW
JACC Cardiovasc Interv; 2020 Dec; 13(23):2795-2803. PubMed ID: 33303119
[TBL] [Abstract][Full Text] [Related]
11. Impact of Diabetes on Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: COAPT Trial.
Shahim B; Ben-Yehuda O; Chen S; Redfors B; Madhavan MV; Kar S; Lim DS; Asch FM; Weissman NJ; Cohen DJ; Arnold SV; Liu M; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
JACC Heart Fail; 2021 Aug; 9(8):559-567. PubMed ID: 34325886
[TBL] [Abstract][Full Text] [Related]
12. Sex-Specific Outcomes of Transcatheter Mitral-Valve Repair and Medical Therapy for Mitral Regurgitation in Heart Failure.
Kosmidou I; Lindenfeld J; Abraham WT; Rinaldi MJ; Kapadia SR; Rajagopal V; Sarembock IJ; Brieke A; Gaba P; Rogers JH; Shahim B; Redfors B; Zhang Z; Mack MJ; Stone GW
JACC Heart Fail; 2021 Sep; 9(9):674-683. PubMed ID: 34391744
[TBL] [Abstract][Full Text] [Related]
13. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
Mack MJ; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Grayburn PA; Rinaldi MJ; Kapadia SR; Rajagopal V; Sarembock IJ; Brieke A; Rogers JH; Marx SO; Cohen DJ; Weissman NJ; Stone GW;
J Am Coll Cardiol; 2021 Mar; 77(8):1029-1040. PubMed ID: 33632476
[TBL] [Abstract][Full Text] [Related]
14. NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial.
Giustino G; Lindenfeld J; Abraham WT; Kar S; Lim DS; Grayburn PA; Kapadia SR; Cohen DJ; Kotinkaduwa LN; Weissman NJ; Mack MJ; Stone GW
JACC Cardiovasc Interv; 2020 Oct; 13(20):2317-2328. PubMed ID: 33092705
[TBL] [Abstract][Full Text] [Related]
15. Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.
Giustino G; Camaj A; Kapadia SR; Kar S; Abraham WT; Lindenfeld J; Lim DS; Grayburn PA; Cohen DJ; Redfors B; Zhou Z; Pocock SJ; Asch FM; Mack MJ; Stone GW
J Am Coll Cardiol; 2022 Nov; 80(20):1857-1868. PubMed ID: 36357085
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation: The COAPT Trial.
Asch FM; Grayburn PA; Siegel RJ; Kar S; Lim DS; Zaroff JG; Mishell JM; Whisenant B; Mack MJ; Lindenfeld J; Abraham WT; Stone GW; Weissman NJ;
J Am Coll Cardiol; 2019 Dec; 74(24):2969-2979. PubMed ID: 31574303
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure: COAPT Trial.
Kar S; Mack MJ; Lindenfeld J; Abraham WT; Asch FM; Weissman NJ; Enriquez-Sarano M; Lim DS; Mishell JM; Whisenant BK; Rogers JH; Arnold SV; Cohen DJ; Grayburn PA; Stone GW
Circulation; 2021 Aug; 144(6):426-437. PubMed ID: 34039025
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.
Baron SJ; Wang K; Arnold SV; Magnuson EA; Whisenant B; Brieke A; Rinaldi M; Asgar AW; Lindenfeld J; Abraham WT; Mack MJ; Stone GW; Cohen DJ;
Circulation; 2019 Dec; 140(23):1881-1891. PubMed ID: 31564137
[TBL] [Abstract][Full Text] [Related]
19. Site-Level Variability in 30-Day Patient Outcomes After Transcatheter Mitral Valve Repair in the United States.
Malik AO; Chhatriwalla AK; Saxon J; Hejjaji V; Stebbins A; Jones PG; Cohen DJ; Arnold SV; Vemulapalli S; Wegermann ZK; Kosinski A; Spertus JA
Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e006878. PubMed ID: 33280434
[TBL] [Abstract][Full Text] [Related]
20. Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT Trial.
Halaby R; Herrmann HC; Gertz ZM; Lim S; Kar S; Lindenfeld J; Abraham WT; Grayburn PA; Naidu S; Asch FM; Weissman NJ; Zhang Y; Mack MJ; Stone GW
JACC Cardiovasc Interv; 2021 Apr; 14(8):879-889. PubMed ID: 33888233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
